{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-21-023805","form_type":"8-K","ticker":"VVOS","cik":"0001716166","company_name":"Vivos Therapeutics, Inc.","filed_at":"2021-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.344625+00:00","generated_at":"2026-06-29T01:19:30.000380+00:00","sec_items":["1.01","5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Founder, CMO & director Dr. Singh takes 12-month sabbatical; resigns from board","bullets":["Sabbatical effective Sept 1, 2021 for 12 months; compensation and benefits unchanged.","Dr. Singh resigned from board of directors effective Sept 22, 2021.","Duties reduced to advising on clinical studies, device development, and conferences.","Board may reinstate or modify duties 30 days before sabbatical ends; extension possible.","Company believes sabbatical will not impact operations; ties to Stanford seen as growth opportunity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-21-023805","json":"https://secwatch.observer/filing/0001493152-21-023805.json","markdown":"https://secwatch.observer/filing/0001493152-21-023805.md","text":"https://secwatch.observer/filing/0001493152-21-023805.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716166/000149315221023805/0001493152-21-023805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716166/000149315221023805/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:19:30.000380+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1e033da959","claim":"Dr. G. Dave Singh resigned as director at Vivos Therapeutics, Inc..","evidence_excerpt":"he has resigned as a member of the Company’s board of directors (the “Board”), effective September 22, 2021.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716166/000149315221023805/0001493152-21-023805-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}